The COVID-19 pandemic has put us in a quagmire. It has given rise to a healthcare crisis. Also, businesses and communities face both economic and humanitarian impacts that test infrastructure, resources, and financial models.
Government, healthcare, and life sciences industries are under tremendous pressure as they are on the front-line in this war against COVID-19. They are trying to respond to this global challenge and are working at an unprecedented pace to find solutions.
In such a scenario, artificial intelligence and automation could be the secret weapons to fight out the global pandemic. The US Food and Drug Administration is also considering adopting AI to speed up its decades-long process of getting new drugs to the market.
In addition, artificial intelligence and automation would help us to stay innovative. Even Accenture has identified AI as a self-running engine for growth, estimating its potential value for the life sciences industry to be $150 billion by 2026.
When it comes to data-rich or document-heavy processes, automation is the key to solving them effectively. In fact, across the industry, AI is imperative for companies looking for scale and agility. It is also helping companies to digitally reinvent pharmaceutical processes in different ways.
Join The Economic Times Live Webinar on Leveraging AI & Automation in Life Sciences during a Health Crisis, powered by Automation Anywhere, to explore:
Real-time analysis and AI-driven decision-making
Data gathering and sharing
Scaling of organizational capabilities
Support for smart supply chains to meet the current crisis
Faster vaccine development to meet future recurrences
 |
||
Sumeet Pathak Digital Workforce Evangelist - IMEA |